Serum insulin-like growth factor-I (IGF-I) reference ranges for chemiluminescence assay in childhood and adolescence. Data from a population of in- and out-patients

G. Bedogni, G. Giannone, M. Maghnie, C. Giacomozzi, N. Di Iorgi, S. Pedicelli, E. Peschiaroli, G. Melioli, M. Muraca, M. Cappa, S. Cianfarani

Research output: Contribution to journalArticle

Abstract

Background: Insulin-like growth factor I (IGF-I) measurement is widely used for the diagnosis of disorders of GH secretion and sensitivity, and for monitoring of both GH and IGF-I replacement therapies. However, the lack of appropriate reference values obtained from large and representative samples undermines its practical utility. Objective: To establish IGF-I reference values for a commonly used enzyme-labeled chemiluminescent immunometric assay in a large population of children aged 0 to 18. years. Design: Cross-sectional analysis of serum IGF-I levels from samples collected in the two major Italian Children's Hospitals. Subjects and methods: IGF-I was measured using a solid-phase, enzyme-labeled chemiluminescent immunometric assay in 24403 children (50.6% girls) aged 0 to 18. years. Quantile regression coupled to multivariable fractional polynomials was used to produce age- and sex-specific reference values. Main outcome measure: Age- and sex-specific IGF-I reference values. Results and conclusion: Reference values for immunometric assay of IGF-I were produced in a large sample of children and adolescents. Prediction equations were provided to automatize their calculations.

Original languageEnglish
Pages (from-to)134-138
Number of pages5
JournalGrowth Hormone and IGF Research
Volume22
Issue number3-4
DOIs
Publication statusPublished - Jun 2012

Fingerprint

Luminescence
Insulin-Like Growth Factor I
Reference Values
Outpatients
Serum
Population
Luminescent Measurements
Enzymes
Cross-Sectional Studies
Outcome Assessment (Health Care)

Keywords

  • GH deficiency
  • Hypopituitarism
  • Insulin-like growth factor-I
  • Reference ranges

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Serum insulin-like growth factor-I (IGF-I) reference ranges for chemiluminescence assay in childhood and adolescence. Data from a population of in- and out-patients. / Bedogni, G.; Giannone, G.; Maghnie, M.; Giacomozzi, C.; Di Iorgi, N.; Pedicelli, S.; Peschiaroli, E.; Melioli, G.; Muraca, M.; Cappa, M.; Cianfarani, S.

In: Growth Hormone and IGF Research, Vol. 22, No. 3-4, 06.2012, p. 134-138.

Research output: Contribution to journalArticle

@article{9ce3b784b96c4ce29308fe7813b806bf,
title = "Serum insulin-like growth factor-I (IGF-I) reference ranges for chemiluminescence assay in childhood and adolescence. Data from a population of in- and out-patients",
abstract = "Background: Insulin-like growth factor I (IGF-I) measurement is widely used for the diagnosis of disorders of GH secretion and sensitivity, and for monitoring of both GH and IGF-I replacement therapies. However, the lack of appropriate reference values obtained from large and representative samples undermines its practical utility. Objective: To establish IGF-I reference values for a commonly used enzyme-labeled chemiluminescent immunometric assay in a large population of children aged 0 to 18. years. Design: Cross-sectional analysis of serum IGF-I levels from samples collected in the two major Italian Children's Hospitals. Subjects and methods: IGF-I was measured using a solid-phase, enzyme-labeled chemiluminescent immunometric assay in 24403 children (50.6{\%} girls) aged 0 to 18. years. Quantile regression coupled to multivariable fractional polynomials was used to produce age- and sex-specific reference values. Main outcome measure: Age- and sex-specific IGF-I reference values. Results and conclusion: Reference values for immunometric assay of IGF-I were produced in a large sample of children and adolescents. Prediction equations were provided to automatize their calculations.",
keywords = "GH deficiency, Hypopituitarism, Insulin-like growth factor-I, Reference ranges",
author = "G. Bedogni and G. Giannone and M. Maghnie and C. Giacomozzi and {Di Iorgi}, N. and S. Pedicelli and E. Peschiaroli and G. Melioli and M. Muraca and M. Cappa and S. Cianfarani",
year = "2012",
month = "6",
doi = "10.1016/j.ghir.2012.04.005",
language = "English",
volume = "22",
pages = "134--138",
journal = "Endocrinology and Metabolism, Supplement",
issn = "1096-6374",
publisher = "Churchill Livingstone",
number = "3-4",

}

TY - JOUR

T1 - Serum insulin-like growth factor-I (IGF-I) reference ranges for chemiluminescence assay in childhood and adolescence. Data from a population of in- and out-patients

AU - Bedogni, G.

AU - Giannone, G.

AU - Maghnie, M.

AU - Giacomozzi, C.

AU - Di Iorgi, N.

AU - Pedicelli, S.

AU - Peschiaroli, E.

AU - Melioli, G.

AU - Muraca, M.

AU - Cappa, M.

AU - Cianfarani, S.

PY - 2012/6

Y1 - 2012/6

N2 - Background: Insulin-like growth factor I (IGF-I) measurement is widely used for the diagnosis of disorders of GH secretion and sensitivity, and for monitoring of both GH and IGF-I replacement therapies. However, the lack of appropriate reference values obtained from large and representative samples undermines its practical utility. Objective: To establish IGF-I reference values for a commonly used enzyme-labeled chemiluminescent immunometric assay in a large population of children aged 0 to 18. years. Design: Cross-sectional analysis of serum IGF-I levels from samples collected in the two major Italian Children's Hospitals. Subjects and methods: IGF-I was measured using a solid-phase, enzyme-labeled chemiluminescent immunometric assay in 24403 children (50.6% girls) aged 0 to 18. years. Quantile regression coupled to multivariable fractional polynomials was used to produce age- and sex-specific reference values. Main outcome measure: Age- and sex-specific IGF-I reference values. Results and conclusion: Reference values for immunometric assay of IGF-I were produced in a large sample of children and adolescents. Prediction equations were provided to automatize their calculations.

AB - Background: Insulin-like growth factor I (IGF-I) measurement is widely used for the diagnosis of disorders of GH secretion and sensitivity, and for monitoring of both GH and IGF-I replacement therapies. However, the lack of appropriate reference values obtained from large and representative samples undermines its practical utility. Objective: To establish IGF-I reference values for a commonly used enzyme-labeled chemiluminescent immunometric assay in a large population of children aged 0 to 18. years. Design: Cross-sectional analysis of serum IGF-I levels from samples collected in the two major Italian Children's Hospitals. Subjects and methods: IGF-I was measured using a solid-phase, enzyme-labeled chemiluminescent immunometric assay in 24403 children (50.6% girls) aged 0 to 18. years. Quantile regression coupled to multivariable fractional polynomials was used to produce age- and sex-specific reference values. Main outcome measure: Age- and sex-specific IGF-I reference values. Results and conclusion: Reference values for immunometric assay of IGF-I were produced in a large sample of children and adolescents. Prediction equations were provided to automatize their calculations.

KW - GH deficiency

KW - Hypopituitarism

KW - Insulin-like growth factor-I

KW - Reference ranges

UR - http://www.scopus.com/inward/record.url?scp=84863785341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863785341&partnerID=8YFLogxK

U2 - 10.1016/j.ghir.2012.04.005

DO - 10.1016/j.ghir.2012.04.005

M3 - Article

C2 - 22583946

AN - SCOPUS:84863785341

VL - 22

SP - 134

EP - 138

JO - Endocrinology and Metabolism, Supplement

JF - Endocrinology and Metabolism, Supplement

SN - 1096-6374

IS - 3-4

ER -